Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Gargi D. Basu"'
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 249-255 (2023)
Locally advanced cholangiocarcinoma has a poor prognosis, with long-term survival only for patients where complete surgical resection is achieved. Median overall survival with chemotherapy alone is less than 1 year. Novel strategies combining convent
Externí odkaz:
https://doaj.org/article/7d4d20c363054d2fb1a8935b330229af
Autor:
Patricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, Winnie S Liang, John Carpten, David W Craig, David B Solit, Alan H Bryce, Jeffrey A Kiefer, Jessica Aldrich, Sara Nasser, Rebecca Halperin, Sara A Byron, Mary Jo Pilat, Scott A Boerner, Diane Durecki, William P D Hendricks, Daniel Enriquez, Tyler Izatt, Jonathan Keats, Christophe Legendre, Svetomir N Markovic, Amy Weise, Fatima Naveed, Jessica Schmidt, Gargi D Basu, Shobana Sekar, Jonathan Adkins, Erica Tassone, Karthigayini Sivaprakasam, Victoria Zismann, Valerie S Calvert, Emanuel F Petricoin, Leslie Anne Fecher, Christopher Lao, J Paul Eder, Nicholas J Vogelzang, Jane Perlmutter, Mark Gorman, Barbara Manica, Lisa Fox, Nicholas Schork, Daniel Zelterman, Michelle DeVeaux, Richard W Joseph, C Lance Cowey, Jeffrey M Trent
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0248097 (2021)
Although combination BRAF and MEK inhibitors are highly effective for the 40-50% of cutaneous metastatic melanomas harboring BRAFV600 mutations, targeted agents have been ineffective for BRAFV600wild-type (wt) metastatic melanomas. The SU2C Genomics-
Externí odkaz:
https://doaj.org/article/ea286e5ad5d3466fb04534c8639561db
Autor:
Anne Kallioniemi, Spyro Mousses, Sukru Tuzmen, Ritva Karhu, Gargi D. Basu, David O. Azorsa, Kimmo Savinainen, Riina Kuuselo
Supplementary Table 2 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e713f03be8d636b063a837dfff60021
https://doi.org/10.1158/0008-5472.22366304.v1
https://doi.org/10.1158/0008-5472.22366304.v1
Autor:
Anne Kallioniemi, Spyro Mousses, Sukru Tuzmen, Ritva Karhu, Gargi D. Basu, David O. Azorsa, Kimmo Savinainen, Riina Kuuselo
Supplementary Table 3 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66f7e263d815f63c57eeb8cb4fe20d8a
https://doi.org/10.1158/0008-5472.22366301
https://doi.org/10.1158/0008-5472.22366301
Autor:
Anne Kallioniemi, Spyro Mousses, Sukru Tuzmen, Ritva Karhu, Gargi D. Basu, David O. Azorsa, Kimmo Savinainen, Riina Kuuselo
Supplementary Table 1 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f4af28a973e5a8bf5d07e79a1fe3d1
https://doi.org/10.1158/0008-5472.22366307
https://doi.org/10.1158/0008-5472.22366307
Autor:
Anne Kallioniemi, Spyro Mousses, Sukru Tuzmen, Ritva Karhu, Gargi D. Basu, David O. Azorsa, Kimmo Savinainen, Riina Kuuselo
Supplementary Table 4 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::903f0599c32af27bf5cee43aae2b4ac7
https://doi.org/10.1158/0008-5472.22366298.v1
https://doi.org/10.1158/0008-5472.22366298.v1
Autor:
Anne Kallioniemi, Spyro Mousses, Sukru Tuzmen, Ritva Karhu, Gargi D. Basu, David O. Azorsa, Kimmo Savinainen, Riina Kuuselo
Pancreatic cancer is a highly aggressive disease characterized by poor prognosis and vast genetic instability. Recent microarray-based, genome-wide surveys have identified multiple recurrent copy number aberrations in pancreatic cancer; however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b71f429e36c0a2f10d4973b8564c3e
https://doi.org/10.1158/0008-5472.c.6495080.v1
https://doi.org/10.1158/0008-5472.c.6495080.v1
Autor:
Anne Kallioniemi, Spyro Mousses, Sukru Tuzmen, Ritva Karhu, Gargi D. Basu, David O. Azorsa, Kimmo Savinainen, Riina Kuuselo
Supplementary Table 5 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28da00a06ede93e1b1870d6a2c6e8422
https://doi.org/10.1158/0008-5472.22366295
https://doi.org/10.1158/0008-5472.22366295
Autor:
Laurie J. Goodman, Thomas Royce, Audrey A. Ozols, Gargi D. Basu, Kevin Drenner, Margaux Steinbach, Janine LoBello, Michael S. Gordon, Sunil Sharma, Erkut Borazanci, Jeffrey M. Trent
Publikováno v:
Oncotarget
Purpose: We present seven cases of advanced cancer patients who initially underwent tumor testing utilizing smaller, panel-based tests, followed by a variety of therapeutic treatments which ultimately resulted in progression of their disease. These c
Autor:
Ryan J. Summers, Sharon M. Castellino, Christopher C. Porter, Tobey J. MacDonald, Gargi D. Basu, Szabolcs Szelinger, Manoj K. Bhasin, Thomas Cash, Alexis B. Carter, Robert Craig Castellino, Jason R. Fangusaro, Sarah G. Mitchell, Melinda G. Pauly, Bojana Pencheva, Daniel S. Wechsler, Douglas K. Graham, Kelly C. Goldsmith
Publikováno v:
JCO Precision Oncology.
PURPOSE Profiling of pediatric cancers through deep sequencing of large gene panels and whole exomes is rapidly being adopted in many clinical settings. However, the most impactful approach to genomic profiling of pediatric cancers remains to be defi